Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.

Shares of Alembic Pharmaceuticals came under pressure on Friday, falling 4.22 per cent to an intraday low of ₹776.20 per share on the NSE, after the company reported a 4 per cent decline in ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.

Alembic Pharmaceuticals Ltd. on Wednesday, October 29, said it has received the US Food and Drug Administration's (USFDA) final approval for its abbreviated new drug application (ANDA) for the ...

The company's current liabilities during FY25 stood at Rs 1 billion as compared to Rs 961 million in FY24, thereby witnessing an increase of 32.8%. Long-term debt stood at Rs 107 million as compared ...

Pivya has been proven safe in three studies. Credit: Summit Art Creations/Shutterstock. Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya ...

Alembic Pharmaceuticals share price: Pharmaceuticals company Alembic Pharmaceuticals shares were trading higher on Thursday, July 3, 2025, with the scrip rising up to 2.05 per cent to hit an intraday ...

Alembic Pharmaceuticals Inc., a wholly owned subsidiary of Alembic Pharmaceuticals Ltd., has acquired Utility Therapeutics Ltd. to expand its UTI drug portfolio in the US. The acquisition includes 100 ...

Alembic Pharmaceuticals Inc., the US subsidiary of Alembic Pharmaceuticals, has acquired Utility Therapeutics Ltd in a $12 million deal to strengthen its presence in the US market. Alembic will begin ...

Shares of Alembic Pharmaceuticals soared more than 12 percent in intra-day trade on Monday, June 30, after the company announced that it had secured final approval from the US Food and Drug ...